433 related articles for article (PubMed ID: 27378336)
1. The BDNF Val66Met polymorphism enhances glutamatergic transmission but diminishes activity-dependent synaptic plasticity in the dorsolateral striatum.
Jing D; Lee FS; Ninan I
Neuropharmacology; 2017 Jan; 112(Pt A):84-93. PubMed ID: 27378336
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the Centromedial Amygdala Glutamatergic Synapses by the BDNF Val66Met Polymorphism.
Galvin C; Lee FS; Ninan I
Neuropsychopharmacology; 2015 Aug; 40(9):2269-77. PubMed ID: 25786582
[TBL] [Abstract][Full Text] [Related]
3. The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus.
Ninan I; Bath KG; Dagar K; Perez-Castro R; Plummer MR; Lee FS; Chao MV
J Neurosci; 2010 Jun; 30(26):8866-70. PubMed ID: 20592208
[TBL] [Abstract][Full Text] [Related]
4. The BDNF Val66Met polymorphism impairs synaptic transmission and plasticity in the infralimbic medial prefrontal cortex.
Pattwell SS; Bath KG; Perez-Castro R; Lee FS; Chao MV; Ninan I
J Neurosci; 2012 Feb; 32(7):2410-21. PubMed ID: 22396415
[TBL] [Abstract][Full Text] [Related]
5. Impaired transmission at corticothalamic excitatory inputs and intrathalamic GABAergic synapses in the ventrobasal thalamus of heterozygous BDNF knockout mice.
Laudes T; Meis S; Munsch T; Lessmann V
Neuroscience; 2012 Oct; 222():215-27. PubMed ID: 22796079
[TBL] [Abstract][Full Text] [Related]
6. Presynaptic and postsynaptic NMDA receptors mediate distinct effects of brain-derived neurotrophic factor on synaptic transmission.
Madara JC; Levine ES
J Neurophysiol; 2008 Dec; 100(6):3175-84. PubMed ID: 18922945
[TBL] [Abstract][Full Text] [Related]
7. Acute stress induces an aberrant increase of presynaptic release of glutamate and cellular activation in the hippocampus of BDNF
Musazzi L; Tornese P; Sala N; Lee FS; Popoli M; Ieraci A
J Cell Physiol; 2022 Oct; 237(10):3834-3844. PubMed ID: 35908196
[TBL] [Abstract][Full Text] [Related]
8. Brain-Derived Neurotrophic Factor Val66Met Human Polymorphism Impairs the Beneficial Exercise-Induced Neurobiological Changes in Mice.
Ieraci A; Madaio AI; Mallei A; Lee FS; Popoli M
Neuropsychopharmacology; 2016 Dec; 41(13):3070-3079. PubMed ID: 27388329
[TBL] [Abstract][Full Text] [Related]
9. Altered balance of glutamatergic/GABAergic synaptic input and associated changes in dendrite morphology after BDNF expression in BDNF-deficient hippocampal neurons.
Singh B; Henneberger C; Betances D; Arevalo MA; Rodríguez-Tébar A; Meier JC; Grantyn R
J Neurosci; 2006 Jul; 26(27):7189-200. PubMed ID: 16822976
[TBL] [Abstract][Full Text] [Related]
10. Glutamatergic Innervation onto Striatal Neurons Potentiates GABAergic Synaptic Output.
Paraskevopoulou F; Herman MA; Rosenmund C
J Neurosci; 2019 Jun; 39(23):4448-4460. PubMed ID: 30936241
[TBL] [Abstract][Full Text] [Related]
11. BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study.
Strube W; Nitsche MA; Wobrock T; Bunse T; Rein B; Herrmann M; Schmitt A; Nieratschker V; Witt SH; Rietschel M; Falkai P; Hasan A
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25612896
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS.
Lessmann V
Gen Pharmacol; 1998 Nov; 31(5):667-74. PubMed ID: 9809461
[TBL] [Abstract][Full Text] [Related]
13. Homeostatic regulation of excitatory synapses on striatal medium spiny neurons expressing the D2 dopamine receptor.
Thibault D; Giguère N; Loustalot F; Bourque MJ; Ducrot C; El Mestikawy S; Trudeau LÉ
Brain Struct Funct; 2016 May; 221(4):2093-107. PubMed ID: 25782435
[TBL] [Abstract][Full Text] [Related]
14. Combination of group I mGlu receptors antagonist with dopaminergic agonists strengthens the synaptic transmission at corticostriatal synapses in culture.
Burguière A; De Bundel D; Valjent E; Roger J; Smolders I; Fagni L; Perroy J
Neuropharmacology; 2013 Mar; 66():151-7. PubMed ID: 22465815
[TBL] [Abstract][Full Text] [Related]
15. Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex.
Liu RJ; Lee FS; Li XY; Bambico F; Duman RS; Aghajanian GK
Biol Psychiatry; 2012 Jun; 71(11):996-1005. PubMed ID: 22036038
[TBL] [Abstract][Full Text] [Related]
16. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
Schotanus SM; Chergui K
J Neurochem; 2008 Aug; 106(4):1758-65. PubMed ID: 18540994
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex.
Ninan I
J Neurochem; 2011 Oct; 119(2):324-31. PubMed ID: 21848811
[TBL] [Abstract][Full Text] [Related]
18. Essential role of presynaptic NMDA receptors in activity-dependent BDNF secretion and corticostriatal LTP.
Park H; Popescu A; Poo MM
Neuron; 2014 Dec; 84(5):1009-22. PubMed ID: 25467984
[TBL] [Abstract][Full Text] [Related]
19. BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity.
Bath KG; Jing DQ; Dincheva I; Neeb CC; Pattwell SS; Chao MV; Lee FS; Ninan I
Neuropsychopharmacology; 2012 Apr; 37(5):1297-304. PubMed ID: 22218094
[TBL] [Abstract][Full Text] [Related]
20. An Increase of Excitatory-to-Inhibitory Synaptic Balance in the Contralateral Cortico-Striatal Pathway Underlies Improved Stroke Recovery in BDNF Val66Met SNP Mice.
Qin L; Actor-Engel HS; Woo MS; Shakil F; Chen YW; Cho S; Aoki C
Neurorehabil Neural Repair; 2019 Dec; 33(12):989-1002. PubMed ID: 31524060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
